mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.001 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.002 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
vincristine |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |